Physician profile
John E Mcdonald
NPI 1780896241
$498,699.02
in general payments reported to CMS, 2019-2025
7 companies · $110K in 2025
The $110K reported for 2025 was more than what 97% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,386 · 2020: $5,188 · 2021: $36K · 2022: $121K · 2023: $96K · 2024: $124K · 2025: $110K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $294K · Consulting Fee: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,219 · Travel and Lodging: $1,821 · Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $293,755.54 |
| Consulting Fee | $26,156.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,218.75 |
| Travel and Lodging | $1,820.64 |
| Food and Beverage | $1,007.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $494,607.56 | 2019-2025 | Coblation, Biceptor, Q-Fix |
| Medinc of Texas | $2,381.55 | 2020-2021 | |
| Stryker Corporation | $1,009.59 | 2022-2025 | Salvation, Inspace, Iconix |
| Medacta USA, INC. | $653.15 | 2021-2023 | Mecta |
| Depuy Synthes Sales INC. | $22.00 | 2022 | |
| Core Surgical Group | $13.82 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.